阿斯利康

202.00
开盘价
199.78
市值
311.30B+
最高价
204.34
最低价
199.23
收盘价
203.49
成交量
2.05M+
市盈率
30.41
股息率
1.55%

阿斯利康简介

AstraZeneca Plc是一家控股公司,从事药品的研究,开发和制造。该公司生产和销售用于胃肠道,心血管,神经科学,呼吸道和炎症,肿瘤学和传染病的药物。其产品线管道包括azd 4831,azd 8601,medi 6012,tagrisso bloom,durvalumab,selumetinib,lyparza polo,epanova,farxiga和brilinta。该公司包括以下品牌销售产品:Atacand,Crestor,Onglyza,Nexium,Entocort,Losec,Merrem / Meronem,Carbocaine,Citanest,Diprivan,Marcaine / Sensorcaine。阿斯利康成立于1992年6月17日,总部位于英国剑桥。

如何购买 阿斯利康 (AZN)

登录
1分钟开户

1分钟开户

仅需1分钟即可完成账户申请和验证。整个过程完全自助,支持 RockFlow App 和网页端操作。

充值资金

充值资金

账户验证完成后,您可以使用首选的支付方式向账户充值。

购买 AZN

购买 AZN

通过 RockFlow App 或网页端搜索 AZN,输入您想要投资的金额,然后点击确认即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.